Market Access has long been treated as a late-stage activity, secondary to HCP marketing and addressed only after approval and launch planning. That thinking assumes access can be solved downstream, once commercial efforts are already in motion.
In reality, Market Access and reimbursement are prerequisites for commercial success. While products can be prescribed without reimbursement, widespread adoption often depends on affordability and coverage. Out-of-pocket payment limits uptake and scalability, making Market Access a core commercial dependency. Download this executive brief to learn more about:
- The right timing for Market Access involvement
- How access affects pricing, evidence, and execution
- Ownership, decision rights, and strategic tradeoffs